Clinical Relevance of CTCs in Primary and Metastatic Breast Cancer
Conference Recording Jan 30, 2014
About the Speaker
Leading Gynecooncologist, Adjacent assistant professor UT , Southwestern Medical School, Dallas Chair of translational research in Gynecological Oncology, University Tuebingen.
The detection of circulating tumor cells in the blood (CTCs) is a common phenomenon seen in 10-20% of primary breast cancer patients. Recent studies have shown a prognostic potential of CTC in both primary and metastatic setting. The evaluation of CTC may become one of the crucial markers for prediction of survival and therapy monitoring.